Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-X-C chemokine receptor type 3B (CXCR3-B) is an isoform of the CXCR3 receptor, a G protein-coupled receptor (GPCR). CXCR3-B is primarily known for its immunoangiostatic role, inhibiting endothelial cell proliferation and angiogenesis, and promoting apoptosis. It binds the CXC chemokines CXCL9, CXCL10, and CXCL11, but elicits different downstream effects compared to the CXCR3-A isoform, which primarily promotes cell migration. CXCR3-B expression is found in various tissues including endothelial cells. Altered expression or function is implicated in cancer (due to its antiangiogenic activity) and autoimmune diseases.
Modulation of cell proliferation, apoptosis, and angiogenesis via GPCR signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C Chemokine Receptor Type 3B (None).